Loading
Latest filing published 17 Mar 2022 for HAVN Life Sciences Inc..
No signal scores available.
All filings by Timothy David Moore on record concern HAVN Life Sciences Inc. We count 2 filings; the first trade dates from 5 May 2020 and the latest from 16 March 2022.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 17 March 2022 with an option exercise in HAVN Life Sciences Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations